Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 7, 2012, Pages 672-678

  Guney, Ahmet Ilter ^a   Ergec, Deniz Sevinc ^b   Tavukcu, Hasan Huseyin ^a   Koc, Gulsah ^a   Kirac, Deniz ^c   Ulucan, Korkut ^a   Javadova, Dilara ^a   Turkeri, Levent ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL YENI YUZYIL UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 6; CYTB PROTEIN; D310 PROTEIN; MITOCHONDRIAL DNA; ND1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; MICRODISSECTION; MITOCHONDRIAL GENE; POLYMERASE CHAIN REACTION; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; DNA, MITOCHONDRIAL; DNA, NEOPLASM; FEMALE; GENES, MITOCHONDRIAL; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84863962809     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0227     Document Type: Article

References (27)

1. Babjuk M, Oosterlinck W, Sylvester R, et al. (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59:997-1008.
2. Bai RK, Leal SM, Covarrubias D, et al. (2007) Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67:4687-4694. (Pubitemid 46910174)
3. Booker LM, Habermacher GM, Jessie BC, et al. (2006) North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 75:468-473.
4. Carew J, Huang P (2006) Mitochondrial defects in cancer. Mol Cancer 1:1-12.
5. Chatterjee A, Mambo E, Sidransky D (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25:4663-4674. (Pubitemid 44187616)
6. Chen G, Chan F, Hong B, et al. (2004) Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer. Oncol Rep 12:463-472.
7. Czarnecka A, Golik P, Bartnik E (2006) Mitochondrial DNA mutations in human neoplasia. J Appl Genet 47:67-78. (Pubitemid 43232163)
8. Darvishi K, Sharma S, Bhat AK, et al. (2007) Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249:249-255. (Pubitemid 46452933)
9. Dasgupta S, Hoque MO, Upadhyay S, et al. (2008) Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 68:700-706. (Pubitemid 351206745)
10. Fliss MS, Usadel H, Caballero OL, et al. (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-2019. (Pubitemid 30158678)
11. Halachmi S, Madeb R, Kravtsov, et al. (2001) Bladder cancer- genetic overview. Med Sci Monit 7:164-168.
12. Hussain SA, Nicholas D, James ND (2005) Molecular markers in bladder cancer. Semin Radiat Oncol 15:3-9. (Pubitemid 40127273)
13. Jeronimo C, Nomoto S, Caballero OL, et al. (2001) Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20:5195-5198. (Pubitemid 32844048)
14. Kroemer G (2006) Mitochondria in cancer. Oncogene 25:4630-4632. (Pubitemid 44187613)
15. Mitra AP, Datar RH, Cote RJ (2006) Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. J Clin Oncol 24:5552-5564. (Pubitemid 46631336)
16. Parrella P, Seripa D, Matera MG, et al. (2003) Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett 190:73-77. (Pubitemid 36109177)
17. Penta JS, Johnson FM, Wachsman JT, et al. (2001) Mitochondrial DNA in human malignancy. Mutat Res 488:119-133. (Pubitemid 32436427)
18. Polyak K, Li Y, Zhu H, et al. (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature Genet 20:291-293. (Pubitemid 28507677)
19. Reznikoff CA, Sarkar S, Jü licher KP, et al. (2000) Genetic alterations and biological pathways in human bladder cancer pathogenesis. Urol Oncol 5:191-203.
20. Ruiz-Pesini E, Lott MT, Procaccio V, et al. (2007) An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res 35 (Database issue):D823-D828. (Pubitemid 46056316)
21. Sanchez-Cespedes M, Parrella P, Nomoto S, et al. (2001) Identification of a mononucleotide repeat as a major target for mi-tochondrial DNA alterations in human tumors. Cancer Res 61:7015-7019. (Pubitemid 32946487)
22. Shidara Y, Yamagata K, Kanamori T, et al. (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65:1655-1663. (Pubitemid 40478589)
23. Taanman J (1999) The mitochondrial genome: structure, transcription and replication. Biochim Biophys Acta 1410:103-123. (Pubitemid 29078599)
24. Tan D-J, Bai R, Wong L-JC (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62:972-976. (Pubitemid 34160271)
25. Taylor R, Turnbull D (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6:389-402. (Pubitemid 40577182)
26. Wada T, Tanji N, Ozawa A, et al. (2006) Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers. Anticancer Res 26:3403-3408. (Pubitemid 44701515)
27. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.